Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 65Myeloid 18Plasma cell 17Lymphoid 13CNS 8Gastrointestinal 7Classical hematology 7Sarcoma 5Dermatologic 5Gynecologic 4Genitourinary 4Tumor-Agnostic 3Thoracic 3Other solid neoplasm 3Breast 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Small Cell 1

Interventions

Carboplatin 1152Cisplatin 876Pemetrexed 834pembrolizumab 608Paclitaxel 598Docetaxel 535Gemcitabine 424Radiotherapy 377Erlotinib Hydrochloride 367Nivolumab 322Bevacizumab 322Etoposide 295durvalumab 254Drug Therapy 233osimertinib 218atezolizumab 208Radiosurgery 190Gefitinib 177Vinorelbine 145130-nm albumin-bound paclitaxel 124Magnetic Resonance Spectroscopy 121Ipilimumab 118Cetuximab 113anlotinib 104tislelizumab 103Topotecan 101Cyclophosphamide 101Taxes 99Irinotecan 95Albumin-Bound Paclitaxel 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Arsenic Trioxide × Thoracic × Clear all
NCT01470248 2021-02-17

Study of Arsenic Trioxide in Small Cell Lung Cancer

Emory University

Phase 2 Completed
20 enrolled 8 charts
Thoracic

Lung Neoplasms, Carcinoma, Small Cell

NCT02066870 2015-03-13

Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI

Betta Pharmaceuticals Co., Ltd.

Phase 1 Unknown
9 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00075426 2013-02-12

Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

The University of Texas Medical Branch, Galveston

Phase 2 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡